3SCHLESINGER M,SILVERMAN L R,JIANG J D,et al.Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear of bone marrow cells in patients with myelodeysplastic syndrome[J]. J Clin Lab Immunol,1996,48:149-166.
4FUCHIGAMI K,MORI H,MATSUO T,et al.Absolute number of circulating CD+34 cells is abnormally low in refractory anemia and extremely high in RAEB and RAEBT;novel pathologic features of myelodysplastic syndromes identified by highly sensitive flow cytomety[J]
5BONDE J,MEYER K,MARIANNE K,et al.Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13.CD14 and CD66 monoclonal antibodies[J]. Br J Haematol,1996,92:269-279.
6DERTEL,OERTEL B,BEYER J,et al.CD34 immunotyping of blast in myelodysplasia[J].Ann Hematol,1994,68:77-80.
7Hokland P, kemdrup G, Griffin J D. Analysis of leukocyte differentiation antigen in blood and bone marrow from preleukemia(refractory anemia)patients using monoclonal antibodies [J]. Blood. 1986,67:898.
8Guyotat D, Campos L, Thomas X, et al. Myelodysplastic syndromes:a study of surface markers and in vitro growh patterns [J]. Am J Hematol, 1990,34:26 - 31.
9Tefferi A, Thibodeau S N. Solberg L A. Clonal studies in the myelodysplastic syndrome using X -linked restriction fragment length polymorphism[J]. Blood,1990,75:1770.
10Jensen IM. Myelopoiesisin myelodysplasia evaluated by multiparam-eter flow cytometry. Leuk lymphoma, 1995 ;20:17 - 25
